ultrasound for relaxing muscles

[rechbill]

Hi, one of my doctors found research from Europe that ultrsound can deactivate trigger points by leaving it in place for 3 minutes over the same location. I have found it to be very effective and have located an inexpensive model that works well. It is a US Pro 2000 at Overstock.com for 90 dollars. I have purchased 3 and made a holder, so I can use them all to cover a large area. Worth a try.

[Violet M]

How's this working for you, Bill? My PT did some ultrasound treatments on me and I found them to be helpful in relaxing the muscles.

Violet

[cpps-admin]

Transperineal ultrasonic therapy for chronic pelvic pain (in males) has had some interesting results, mostly from peripheral countries at this stage, for example

Zhonghua Nan Ke Xue. 2013 Jan;19(1):49-53.
[Transperineal ultrasonic therapy for chronic prostatitis].
[Article in Chinese]
Li HS, Wang B, Han L, Wang CH, Xin ZC.
Department of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China. 1028bj@sina.com

OBJECTIVE: To evaluate the clinical efficacy and safety of transperineal ultrasonic therapy for chronic prostatitis (CP) by analyzing the scores of NIH-CPSI and the results of prostate fluid routine examination.

METHODS: We conducted a randomized, double-blind, multi-centered trial on 96 CP patients that met the inclusion criteria. We divided the patients into groups A (trial) and B (control) of equal number, the former treated by transperineal ultrasound, while the latter with the same machine but no ultrasound waves, 10 min a time qd alt for 2 weeks. Then we evaluated the therapeutic effect and safety by comparing the scores of NIH-CP-SI and counts of white blood cells (WBC) and lecithin corpuscles (LC) in the prostate fluid between the two groups before and after treatment.

RESULTS: The total effectiveness rate was 70.83% in group A and 25% in group B (P < 0.01). The scores on prostate pain, urinary symptoms and quality of life as well as the total NIH-CPSI score were significantly improved in group A as compared with pretreatment (P < 0.05), and so were the prostate pain score and total NIH-CPSI score in group B (P < 0.05). Statistically significant differences were observed between the two groups in the scores on prostate pain and urinary symptoms and total NIH-CPSI score after treatment (P < 0.05), but not in any of the NIH-CPSI scores before treatment (P > 0.05), nor were there any significant differences in the counts of WBCs and LC either between the two groups or within each group before and after treatment (P > 0.05). Two patients experienced adverse events in group A, and 1 in group B (P > 0.05).

CONCLUSION: Transperineal ultrasonic therapy is highly effective for CP, especially in relieving prostate pain. With its advantages of safety, easy operation and high acceptability, it deserves a wider clinical application.

PMID: 23469662